The Court of Appeals for the Federal Circuit has vacated a lower court's ruling in Gemstar-TV Guide and SuperGuide's lawsuit against satellite broadcaster EchoStar Communications over patents for on-screen program guides.
The U.S. Court of Appeals for the Federal Circuit on Wednesday dismissed a patent infringement ruling against Intel in a high-stakes dispute with Intergraph Corp., a move that lets the chip maker avoid a $100 million penalty.
U.S. regulators are preparing an appeal of a recent court decision that barred the Food and Drug Administration from granting shared 180-day exclusivity to several makers of generic versions of branded drugs.
The U.S. Court of Appeals for the Federal Circuit has affirmed a lower court’s decision to dismiss Multi-Tech’s patent infringement lawsuit against internet telephony provider Net2Phone.
The Supreme Court of India has issued a ruling that will help copyright, patent and trademark owners obtain faster preliminary injunctions against alleged infringers.
A Chinese court has started hearing arguments in a Taiwanese chip maker’s lawsuit against Motorola over copyrights for a printed circuit board used in cellular phones.
A federal appeals court has ruled that the courts do not have original jurisdiction in cases involving concurrent trademarks, and can only become involved after the U.S. Patent and Trademark Office issues a decision.
The Trademark Trial and Appeal Board of the U.S. Patent and Trademark Office has dismissed Miami-based Bacardi U.S.A.'s long-running claim to the Havana Club rum label.
The Ninth Circuit Court of Appeal will hear a landmark case Tuesday that will likely shape the entertainment industry’s legal strategy in its campaign against illegal file sharing on the internet.
The U.S. Court of Appeals for the Federal Circuit has vacated a lower court’s decision that supported Israeli generics maker Teva's right to sell a generic form of Schwarz Pharma’s hypertension drug Univasc.
The Court of Appeals for the Federal Circuit has upheld a lower court’s decision against GlaxoSmithKline over generics maker Impax Laboratories’ abbreviated new drug applications for certain dosages of Wellbutrin and Zyban.
The Board of Patent Appeals and Interferences of the U.S. Patent and Trademark Office has issued a final judgment in favor of Geron in the patent interference proceeding between Geron and Infigen over claims to nuclear transfer technology used to clone animals.
The U.S. Court of Appeals for the Federal Circuit has denied a petition for a rehearing from French chip equipment maker Soitec and the French research organization CEA to overturn the jury verdict that invalidated the major claims of Soitec's primary "Smart-Cut” patent.
America Online settled a trademark dispute with Playboy Enterprises Inc. on Thursday, just days after a three-judge panel of the 9th U.S. Circuit Court of Appeals reinstated Playboy’s lawsuit.
The U.S. Court of Appeals for the Ninth Circuit has denied an appeal by the granddaughter of British author A.A. Milne and the Walt Disney Co. to recapture the rights under copyright to Winnie the Pooh from the Slesinger family.
The U.S. District Appeals Court for the District of Columbia rejected a challenge from generic drug maker Apotex and upheld rival Alpharma’s 180-day marketing exclusivity period for gabapentin capsules.
Canada’s Supreme Court will hear arguments Tuesday in a high-profile case that pits a farmer against U.S. agricultural giant Monsanto over the right to patent life forms.
Canadian industry groups representing retailers, electronics makers and recording companies have filed separate court appeals to reverse a Copyright Board decision that imposed a piracy levy on digital audio recorders.
In a case with wide implications for online advertising, a three-judge panel of the 9th U.S. Circuit Court of Appeals on Wednesday reinstated a trademark infringement lawsuit by Playboy against Netscape.
Purdue Pharma has filed an appeal of a court ruling that found its patents protecting the painkiller OxyContin were invalid because the company deliberately misled the U.S. Patent Office.